Kevin Rieger
About Kevin Rieger
Kevin Rieger is the Director of Corporate Affairs at BeiGene in München, with a background in public health and extensive experience in the pharmaceutical industry.
Professional Role at BeiGene
Kevin Rieger is currently serving as Director of Corporate Affairs at BeiGene in München, Bayern, Deutschland. In this role, he is focusing on shaping the healthcare environment to support innovative business models and improve health outcomes, reflecting his passion for healthtech and its transformative potential in the healthcare sector.
Previous Experience at Ipsen Pharma GmbH
From 2020 to 2022, Kevin Rieger worked at Ipsen Pharma GmbH as Government Affairs Manager for the DACH region in München, Bayern, Deutschland. During his tenure, he was involved in government relations and regulatory affairs, helping to navigate the complex landscape of pharmaceutical regulations in Germany, Austria, and Switzerland.
Role at Bundesverband der Pharmazeutischen Industrie
Kevin Rieger served as Head of European Affairs at the Bundesverband der Pharmazeutischen Industrie from 2016 to 2019. Based in Brüssel und Umgebung, Belgien, his responsibilities included managing European policy issues, representing the interests of German pharmaceutical companies in European institutions, and fostering relationships with key stakeholders across the EU.
Education and Academic Background
Kevin Rieger has a robust academic background with degrees from several prestigious institutions. He earned a Master of Business Administration (MBA) from Quadriga University of Applied Sciences (2018-2019), a Master of Science (M.Sc.) in European Public Health from Maastricht University (2014-2015), and a Bachelor of Science (B.Sc.) in European Public Health also from Maastricht University (2011-2014). Additionally, he studied Human Nutrition at Università degli Studi di Milano in 2013 and completed his A-levels at Gymnasium der Stadt Baesweiler (2000-2009).
Passion for HealthTech
Kevin Rieger is passionate about leveraging healthtech to transform healthcare. He believes that the future of healthcare is data-driven and actively works to integrate these principles into his professional endeavors. His dedication to innovative healthcare solutions aims to improve health outcomes and revolutionize the healthcare industry.